Of the genetic lesions identified in JMML, the protein tyrosine phosphatasePTPN11 (SHP-2), a positive regulator of RAS signaling9,10, is the mostfrequently mutated (heterozygous)11,12. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.